XBI just recently broke out of a major range and is now on its way to retake the 200 wk moving average. With many biotechs breaking out of early bases, XBI looks likely to break to the upside.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.